Celcuity Inc. (NASDAQ:CELC) Q1 2025 Earnings Conference Call May 14, 2025 4:30 PM ET
Company Participants
Apoorva Chaloori - ICR Healthcare
Brian Sullivan - Chief Executive Officer and Co-Founder
Vicky Hahne - Chief Financial Officer
Conference Call Participants
Maury Raycroft - Jefferies
Tara Bancroft - TD Cowen
Gil Blum - Needham and Company
Oliver McCammon - LifeSci Capital
Operator
Good afternoon, ladies and gentlemen, and welcome to the Celcuity First Quarter 2025 Financial Results Webcast Conference Call. At this time all lines are in listen-only mode. [Operator Instruction]
I would now like to turn the conference over to Apoorva Chaloori with ICR Healthcare. Please go ahead.
Apoorva Chaloori
Thank you, operator, and good afternoon to everyone. Thank you for joining us to review Celcuity’s first quarter 2025 financial results and business update.
Earlier today, Celcuity Inc. released financial results for the first quarter ended March 31, 2025. The press release can be found on the Investors section of Celcuity’s website.
Joining me on the call today are Brian Sullivan, Celcuity’s Chief Executive Officer and Co-Founder; Vicky Hahne, Chief Financial Officer as well as Igor Gorbatchevsky, Chief Medical Officer, who will be available during Q&A.
Before we begin, I would like to remind listeners that our comments today will include some forward-looking statements. These statements involve a number of risks and uncertainties, which are outlined in today’s press release and in our reports and filings with the SEC.
Actual events or results may differ materially from those projected in the forward-looking statements. Such forward-looking statements and their implications involve known and unknown risks, uncertainties and other factors that may cause actual results or performance to differ materially from those projected.
On this call, we will also refer to non-GAAP financial measures. These non-GAAP measures are used by management to make strategic decisions, forecast future
- Read more current CELC analysis and news
- View all earnings call transcripts